Valuation : DIAGNOS Inc.

Market Cap 5.42Cr 3.91Cr 3.37Cr 3.19Cr 2.89Cr 373.15Cr 5.45Cr 38Cr 15Cr 189.84Cr 15Cr 14Cr 599.89Cr P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 5.37Cr 3.87Cr 3.33Cr 3.16Cr 2.86Cr 369.54Cr 5.39Cr 37Cr 14Cr 188Cr 15Cr 14Cr 594.07Cr EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
93.19%
Yield 2025 *
-
Yield 2026 -
1 day+3.45%
1 week-5.26%
Current month-10.00%
1 month+16.88%
3 months+125.00%
6 months+52.54%
Current year+20.00%
1 week 0.42
Extreme 0.42
0.47
1 month 0.38
Extreme 0.375
0.52
Current year 0.18
Extreme 0.175
0.52
1 year 0.18
Extreme 0.175
0.52
3 years 0.18
Extreme 0.175
0.58
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
28/08/26 Buy

Director

1,05,000 0.0872%
21/08/26 Option

Director

-1,00,000 0.0830%
21/08/26 Option

Director

1,00,000 0.0830%
Change 5-day change 1-year change 3-year change Capi.($)
+3.45%-5.26%+80.00%-22.41% 3.91Cr
+3.96%+3.58%-4.00%+66.30% 23TCr
-0.22%-2.43%+48.76%+97.20% 12TCr
+3.37%-1.51%-22.91%-41.60% 11TCr
-0.15%-4.48%-29.76%-38.54% 8.33TCr
-0.76%-5.53%-28.05%-8.94% 5.85TCr
+0.12%-8.17%-31.98%-30.87% 4.4TCr
-1.03%-3.87%-0.82%+102.48% 4.23TCr
-1.11%-6.05%-1.92%+175.64% 3.92TCr
-0.07%-6.75%-17.80%-5.95% 3.42TCr
Average +0.76%-4.05%-0.85%+29.33% 7.59TCr
Weighted average by Cap. +1.48%-1.74%-5.38%+36.50%

Financials

2025 2026
Net sales 1L 74.82T 64.47T 61.04T 55.33T 71.48L 1L 7L 3L 36.37L 3L 3L 1.15Cr 65.48T 47.2T 40.67T 38.51T 34.9T 45.09L 65.81T 5L 2L 22.94L 2L 2L 72.49L
Net income -42.86L -30.9L -26.62L -25.21L -22.85L -30Cr -43.08L -2.99Cr -1.15Cr -15Cr -1.16Cr -1.13Cr -47Cr -45.55L -32.84L -28.29L -26.79L -24.28L -31Cr -45.78L -3.18Cr -1.22Cr -16Cr -1.23Cr -1.21Cr -50Cr
Net Debt -2L -1L -1L -96.27T -87.26T -1.13Cr -2L -11.43L -4L -57.36L -4L -4L -1.81Cr -5L -4L -3L -3L -3L -3.62Cr -5L -36.68L -14.1L -1.84Cr -14.22L -13.9L -5.81Cr
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
11/26/11 CA$0.4500 +3.45% 2,26,310
10/26/10 CA$0.4350 +1.16% 1,25,359
09/26/09 CA$0.4300 -4.44% 1,36,075
08/26/08 CA$0.4500 -5.26% 2,61,358
04/26/04 CA$0.4750 -1.04% 61,732

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!